Clinical Trial Info

  • Category


Non Alcoholic Steatohepatitis (NASH) is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver.

 NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes.  If you are living with NASH you may qualify for a clinical research study. Study Details
Liver-biopsy Proven NASH
A phase 2b randomized, double blind, placebo-controlled, multicenter study evaluating safety and efficacy of EDP-305 in subjects with liver-biopsy proven non-alcoholic steatohepatitis (NASH) (ARGON-2)

Contact Research
Photo of Ana Corregidor MD
Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.